Status:
TERMINATED
Endothelial Progenitor Cells in Umbilical Cord Blood in Preeclampsia and IUGR
Lead Sponsor:
Medical University of South Carolina
Conditions:
Preeclampsia
IUGR
Eligibility:
FEMALE
18-45 years
Brief Summary
The objective of this study is to determine whether there are alterations in the population of endothelial progenitor cells in umbilical cord blood samples of infants born in the setting of maternal p...
Detailed Description
Preeclampsia remains a significant cause of neonatal and maternal morbidity and mortality. This disorder is found in 5-7% of pregnancies and its incidence is increased in gravid patients with multiple...
Eligibility Criteria
Inclusion
- Pregnant women 18-45
- Gestational age between 30-40 weeks plus:
- Uncomplicated pregnancy or
- Fetal estimated weight \<10% for gestational age or abdominal circumference \<5% or
- Preeclampsia by ACOG criteria:
- HTN \> 140/90 on two occasions
- Proteinuria \> 300mg on 24 hour urine specimen or 1+ on urine dip
Exclusion
- Non-reassuring fetal status
- Congenital abnormalities
- Multiple gestations
- Clinical Chorioamnionitis
- Recent infectious disease (within 2 weeks)
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00634855
Start Date
March 1 2008
End Date
March 1 2012
Last Update
June 15 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425